Response to Letters Regarding Article, “Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis”

Year: 2016

Type: article

Abstract: Comment on: Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. [Circulation. 2015] \nLetter by Cohen and Maurer Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis". [Circulation. 2016]

Source: Circulation

DOI: 10.1161/circulationaha.116.021162

Institutions: University College Hospital at Westmoreland Street, The Royal Free Hospital, University College London, University of Bristol, University of Pittsburgh, National Institutes of Health, National Heart, Lung, and Blood Institute

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute for Health and Care Research, British Heart Foundation, National Institutes of Health

Awards: G4705346009, The clinical significance of diffuse myocardial fibrosis in cardiomyopathy, The Role of Diffuse Myocardial Fibrosis in Aortic Stenosis: Translation of Non-Invasive Quantification into Clinical Practice, Anti-atherogenic effects of anti-platelet drugs in patients with silent atherosclerosis

OpenAlex ID: W2311049940